Logo image of TLYS

TILLY'S INC-CLASS A SHRS (TLYS) Stock Fundamental Analysis

NYSE:TLYS - New York Stock Exchange, Inc. - US8868851028 - Common Stock - Currency: USD

1.7  0 (0%)

After market: 1.7 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TLYS. TLYS was compared to 121 industry peers in the Specialty Retail industry. TLYS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TLYS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TLYS has reported negative net income.
In the past year TLYS has reported a negative cash flow from operations.
In multiple years TLYS reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: TLYS reported negative operating cash flow in multiple years.
TLYS Yearly Net Income VS EBIT VS OCF VS FCFTLYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

The Return On Assets of TLYS (-13.50%) is worse than 79.34% of its industry peers.
With a Return On Equity value of -45.83%, TLYS is not doing good in the industry: 69.42% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -13.5%
ROE -45.83%
ROIC N/A
ROA(3y)-6.5%
ROA(5y)-1.4%
ROE(3y)-21.38%
ROE(5y)-5.62%
ROIC(3y)N/A
ROIC(5y)N/A
TLYS Yearly ROA, ROE, ROICTLYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

With a Gross Margin value of 26.29%, TLYS is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
TLYS's Gross Margin has declined in the last couple of years.
TLYS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-2.7%
TLYS Yearly Profit, Operating, Gross MarginsTLYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

TLYS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TLYS has been increased compared to 1 year ago.
TLYS has more shares outstanding than it did 5 years ago.
There is no outstanding debt for TLYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TLYS Yearly Shares OutstandingTLYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
TLYS Yearly Total Debt VS Total AssetsTLYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 1.15, we must say that TLYS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.15, TLYS is not doing good in the industry: 67.77% of the companies in the same industry are doing better.
There is no outstanding debt for TLYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.15
ROIC/WACCN/A
WACC9.25%
TLYS Yearly LT Debt VS Equity VS FCFTLYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

TLYS has a Current Ratio of 1.32. This is a normal value and indicates that TLYS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TLYS (1.32) is comparable to the rest of the industry.
TLYS has a Quick Ratio of 1.32. This is a bad value and indicates that TLYS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.62, TLYS perfoms like the industry average, outperforming 59.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.62
TLYS Yearly Current Assets VS Current LiabilitesTLYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

TLYS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -138.75%.
Looking at the last year, TLYS shows a decrease in Revenue. The Revenue has decreased by -8.61% in the last year.
Measured over the past years, TLYS shows a decrease in Revenue. The Revenue has been decreasing by -1.66% on average per year.
EPS 1Y (TTM)-138.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.71%
Revenue 1Y (TTM)-8.61%
Revenue growth 3Y-9.79%
Revenue growth 5Y-1.66%
Sales Q2Q%-14.87%

3.2 Future

Based on estimates for the next years, TLYS will show a very strong growth in Earnings Per Share. The EPS will grow by 26.97% on average per year.
The Revenue is expected to grow by 2.04% on average over the next years.
EPS Next Y17.56%
EPS Next 2Y24.34%
EPS Next 3Y26.97%
EPS Next 5YN/A
Revenue Next Year-5.31%
Revenue Next 2Y-0.19%
Revenue Next 3Y2.04%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TLYS Yearly Revenue VS EstimatesTLYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
TLYS Yearly EPS VS EstimatesTLYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TLYS. In the last year negative earnings were reported.
Also next year TLYS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLYS Price Earnings VS Forward Price EarningsTLYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TLYS Per share dataTLYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as TLYS's earnings are expected to grow with 26.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.34%
EPS Next 3Y26.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TLYS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TILLY'S INC-CLASS A SHRS

NYSE:TLYS (4/23/2025, 8:04:00 PM)

After market: 1.7 0 (0%)

1.7

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)06-04 2025-06-04/amc
Inst Owners98.15%
Inst Owner Change0.95%
Ins Owners1.96%
Ins Owner Change0%
Market Cap51.26M
Analysts45.71
Price Target2.55 (50%)
Short Float %4.12%
Short Ratio8.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.48%
Min EPS beat(2)-49.55%
Max EPS beat(2)-13.41%
EPS beat(4)1
Avg EPS beat(4)-0.12%
Min EPS beat(4)-49.55%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)18.3%
EPS beat(12)7
Avg EPS beat(12)60.84%
EPS beat(16)10
Avg EPS beat(16)185.14%
Revenue beat(2)0
Avg Revenue beat(2)-4.92%
Min Revenue beat(2)-9.69%
Max Revenue beat(2)-0.14%
Revenue beat(4)0
Avg Revenue beat(4)-3.52%
Min Revenue beat(4)-9.69%
Max Revenue beat(4)-0.14%
Revenue beat(8)1
Avg Revenue beat(8)-2.13%
Revenue beat(12)2
Avg Revenue beat(12)-1.65%
Revenue beat(16)5
Avg Revenue beat(16)0.83%
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)-53.49%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-90%
EPS NY rev (3m)-90%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)-9.38%
Revenue NY rev (1m)-6.46%
Revenue NY rev (3m)-6.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 0.51
P/tB 0.51
EV/EBITDA N/A
EPS(TTM)-1.53
EYN/A
EPS(NY)-1.26
Fwd EYN/A
FCF(TTM)-1.67
FCFYN/A
OCF(TTM)-1.39
OCFYN/A
SpS18.89
BVpS3.35
TBVpS3.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.5%
ROE -45.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.29%
FCFM N/A
ROA(3y)-6.5%
ROA(5y)-1.4%
ROE(3y)-21.38%
ROE(5y)-5.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.67%
GM growth 5Y-2.7%
F-Score3
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 64.4%
Cap/Sales 1.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.62
Altman-Z 1.15
F-Score3
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)93.39%
Cap/Depr(5y)80.87%
Cap/Sales(3y)1.98%
Cap/Sales(5y)1.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-138.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.71%
EPS Next Y17.56%
EPS Next 2Y24.34%
EPS Next 3Y26.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.61%
Revenue growth 3Y-9.79%
Revenue growth 5Y-1.66%
Sales Q2Q%-14.87%
Revenue Next Year-5.31%
Revenue Next 2Y-0.19%
Revenue Next 3Y2.04%
Revenue Next 5YN/A
EBIT growth 1Y-67.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.88%
EBIT Next 3Y32.43%
EBIT Next 5YN/A
FCF growth 1Y-142.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-524.06%
OCF growth 3YN/A
OCF growth 5YN/A